Na+-K+-2Cl- cotransport in Ehrlich cells: regulation by protein phosphatases and kinases

Am J Physiol. 1998 Jul;275(1):C239-50. doi: 10.1152/ajpcell.1998.275.1.C239.

Abstract

To identify protein kinases (PK) and phosphatases (PP) involved in regulation of the Na+-K+-2Cl- cotransporter in Ehrlich cells, the effect of various PK and PP inhibitors was examined. The PP-1, PP-2A, and PP-3 inhibitor calyculin A (Cal-A) was a potent activator of Na+-K+-2Cl- cotransport (EC50 = 35 nM). Activation by Cal-A was rapid (<1 min) but transient. Inactivation is probably due to a 10% cell swelling and/or the concurrent increase in intracellular Cl- concentration. Cell shrinkage also activates the Na+-K+-2Cl- cotransport system. Combining cell shrinkage with Cal-A treatment prolonged the cotransport activation compared with stimulation with Cal-A alone, suggesting PK stimulation by cell shrinkage. Shrinkage-induced cotransport activation was pH and Ca2+/calmodulin dependent. Inhibition of myosin light chain kinase by ML-7 and ML-9 or of PKA by H-89 and KT-5720 inhibited cotransport activity induced by Cal-A and by cell shrinkage, with IC50 values similar to reported inhibition constants of the respective kinases in vitro. Cell shrinkage increased the ML-7-sensitive cotransport activity, whereas the H-89-sensitive activity was unchanged, suggesting that myosin light chain kinase is a modulator of the Na+-K+-2Cl- cotransport activity during regulatory volume increase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azepines / pharmacology
  • Bradykinin / pharmacology
  • Carbazoles*
  • Carcinoma, Ehrlich Tumor / metabolism*
  • Carcinoma, Ehrlich Tumor / physiopathology
  • Carrier Proteins / metabolism*
  • Chlorides / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Enzyme Inhibitors / pharmacology*
  • Homeostasis
  • Hypertonic Solutions
  • Indoles / pharmacology
  • Isoquinolines / pharmacology
  • Kinetics
  • Marine Toxins
  • Mice
  • Myosin-Light-Chain Kinase / antagonists & inhibitors
  • Naphthalenes / pharmacology
  • Osmolar Concentration
  • Oxazoles / pharmacology
  • Phosphoprotein Phosphatases / metabolism*
  • Potassium / metabolism*
  • Protein Kinases / metabolism*
  • Pyrroles / pharmacology
  • Sodium-Potassium-Chloride Symporters
  • Sulfonamides*
  • Tumor Cells, Cultured

Substances

  • Azepines
  • Carbazoles
  • Carrier Proteins
  • Chlorides
  • Enzyme Inhibitors
  • Hypertonic Solutions
  • Indoles
  • Isoquinolines
  • Marine Toxins
  • Naphthalenes
  • Oxazoles
  • Pyrroles
  • Sodium-Potassium-Chloride Symporters
  • Sulfonamides
  • ML 9
  • ML 7
  • KT 5720
  • calyculin A
  • Protein Kinases
  • Cyclic AMP-Dependent Protein Kinases
  • Myosin-Light-Chain Kinase
  • Phosphoprotein Phosphatases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • Potassium
  • Bradykinin